Thus, expanding Vγ2Vδ2 T cells with pulse zoledronate stimulation and either IL-18/IL-2, IL-21/IL-15, or IL-21/IL-2 could increase their anti-tumor immunity. The gene discussed is IL2; the disease is neoplasm.